Literature DB >> 8993833

Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line.

H Kuniyasu1, W Yasui, K Kitahara, K Naka, H Yokozaki, Y Akama, T Hamamoto, H Tahara, E Tahara.   

Abstract

The effect of IFN-beta on cell growth and the mechanism of growth modulation was examined in human gastric carcinoma cell lines. IFN-beta inhibited the cell growth of TMK-1 cells, whereas it did not affect the growth of the other three cell lines (MKN-7, -28, and -45). The number of apoptotic cells in IFN-beta-treated TMK-1 cells was 2-fold the number of those in control TMK-1 cells, whereas the induction of apoptosis was not observed in IFN-beta-treated MKN-28 cells. IFN-beta enhanced the expression of cyclin-dependent kinase inhibitor p27Kip1 at mRNA and protein levels. The increased p27Kip1 bound preferentially to CDK6. The phosphorylation level of retinoblastoma protein in TMK-1 cells was reduced by IFN-beta treatment. IFN-beta did not affect the expression of cell cycle regulators in MKN-28 cells. These results suggest that the induction of p27Kip1 by IFN-beta might confer inhibition of cell growth, leading to subsequent apoptosis in TMK-1 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8993833

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

Review 1.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  Peritoneal metastasis inhibition by linoleic acid with activation of PPARgamma in human gastrointestinal cancer cells.

Authors:  Takamitsu Sasaki; Kiyomu Fujii; Kazuhiro Yoshida; Hideo Shimura; Tomonori Sasahira; Hitoshi Ohmori; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2005-12-16       Impact factor: 4.064

3.  Conjugated linoleic acid reduced metastasized LL2 tumors in mouse peritoneum.

Authors:  Yasuha Sakai; Tomonori Sasahira; Hitoshi Ohmori; Kazuhiro Yoshida; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2006-08-08       Impact factor: 4.064

4.  Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells.

Authors:  Takamitsu Sasaki; Kazuhiro Yoshida; Hideaki Kondo; Hitoshi Ohmori; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2005-04-15       Impact factor: 4.064

5.  Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages.

Authors:  Hiroki Kuniyasu; Seiji Yano; Takamitsu Sasaki; Tomonori Sasahira; Sabro Sone; Hitoshi Ohmori
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  Reg IV enhances peritoneal metastasis in gastric carcinomas.

Authors:  H Kuniyasu; N Oue; T Sasahira; L Yi; Y Moriwaka; T Shimomoto; K Fujii; H Ohmori; W Yasui
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

7.  Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells.

Authors:  K Fujii; Y Luo; T Sasahira; A Denda; H Ohmori; H Kuniyasu
Journal:  Cell Prolif       Date:  2009-07-06       Impact factor: 6.831

8.  Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models.

Authors:  Chihiro Koba; Miwa Haruta; Yusuke Matsunaga; Keiko Matsumura; Eriko Haga; Yuko Sasaki; Tokunori Ikeda; Koutaro Takamatsu; Yasuharu Nishimura; Satoru Senju
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  Inhibition of cyclin D1 expression and induction of apoptosis by inostamycin in small cell lung carcinoma cells.

Authors:  M Imoto; K Tanabe; S Simizu; E Tashiro; M Takada; K Umezawa
Journal:  Jpn J Cancer Res       Date:  1998-03

10.  Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.

Authors:  W Yasui; Y Kudo; S Semba; H Yokozaki; E Tahara
Journal:  Jpn J Cancer Res       Date:  1997-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.